Based on their published scientific articles, two University at Buffalo physician-scientists have been recognized as leading investigators in their medical specialties by the global health care information website Expertscape.
Leonard H. Epstein, PhD, SUNY Distinguished Professor of pediatrics, has been named a fellow of the American Association for the Advancement of Science in recognition of his distinguished contributions to the prevention and treatment of childhood obesity.
Actively seeking and successfully obtaining a creative mix of funding, Matthew J. Barth, MD, research assistant professor of pediatrics, is pursuing promising research aimed at helping children with B-cell non-Hodgkin lymphoma overcome resistance to treatment.
To advance promising research on schizophrenia, the Patrick P. Lee Foundation will fund long-term fellowships for three advanced research trainees in the lab of Michal K. Stachowiak, PhD, professor of pathology and anatomical sciences.
Dementia and Alzheimer’s disease may be related to a vascular abnormality in the internal jugular veins, according to a revealing pilot study by an international research team, including University at Buffalo scientists.
With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.
With a focus on the Escherichia coli bacterium, Mark Sutton, PhD, associate professor of biochemistry, will build on a decade of research to further study the complex coordination of molecular mechanisms that contribute to mutations in DNA replication and repair.
University at Buffalo scientists are expanding their innovative, hands-on training program to engage hundreds of area high school students in the thrill of cutting-edge bioinformatics discovery.
At the 2013 Honors Convocation ceremony, 156 medical students were recognized for their meritorious performance in coursework and outstanding achievements.
Through her fledgling start-up firm, University at Buffalo researcher Kate Rittenhouse-Olson, PhD ’84, is turning a mouse antibody she created into a promising cancer-fighting therapy for humans.
In the quest to find a pharmaceutical target to repair myelin — the nerve sheath destroyed in multiple sclerosis — University at Buffalo researchers aim to test a drug that blocks the activity of the M3 receptor gene.
The University at Buffalo’s family medicine department is teaming up with UB residents, medical students and the Patient Voices Network to increase breast cancer awareness and screening among Buffalo women.
As the Patient Protection and Affordable Care Act (ACA) begins to reshape the American health care system, the University at Buffalo is working to ensure that current and future health care professionals are ready to take on new challenges.
Carroll McWilliams (Mac) Harmon, MD, PhD, an internationally recognized leader in minimally invasive surgery and the treatment of adolescent obesity, has been named professor and chief of pediatric surgery in the University at Buffalo’s Department of Surgery.
Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine, will direct a new national center aimed at training physicians to address addiction through early intervention and prevention.
A University at Buffalo study has found that behavioral interventions that improve delay of gratification can work just as well with overweight and obese women as with lean women.
A joint University at Buffalo-Yale University study published in Circulation has found that the small molecule MIF20 can significantly reduce the amount of heart muscle damaged by myocardial infarction.
University at Buffalo translational researchers have confirmed in humans a link between LDL (“bad”) cholesterol levels and stem cells in the bloodstream that form atherosclerosis-causing inflammatory cells.
